Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Sensory Organ Drugs - China

China
  • In China, the revenue in the Sensory Organ Drugs market is estimated to reach US$2.70bn by 2024.
  • The market is expected to grow at an annual growth rate (CAGR 2024-2029) of -2.89%, leading to a market volume of US$2.33bn by 2029.
  • When comparing globally, United States is projected to generate the highest revenue, amounting to US$13.98bn in 2024.
  • China's growing middle class is driving demand for sensory organ drugs, resulting in a booming market for companies in the pharmaceutical industry.

Definition:
This market covers ophthalmologicals and otologicals, i.e., drugs for the sensory organs eye and ear, respectively. Ophthalmologicals are used to treat diseases of the eye such as wet age-related macular degeneration, geographic atrophy, and glaucoma. Typical dosage forms are eye drops or injections into the eye (intravitreal) and, in the case of otologicals, through the eardrum into the middle ear.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Regeneron Pharmaceuticals, Novartis, Bayer, Alcon, AbbVie

In-Scope

  • Ophthalmologicals
  • Otologicals

Out-Of-Scope

  • Respiratory system
  • Ophthalmic devices, such as diagnostic and surgical devices or glasses and contact lenses
  • Dermatology, skin treatment
  • Painkillers, analgesics
Sensory Organs Drugs: market data & analysis - Cover

Market Insights report

Sensory Organs Drugs: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Analyst Opinion

    China, being one of the largest countries in the world, holds a significant position in the global market. The Sensory Organ Drugs market in China has been experiencing a steady growth rate over the past few years.

    Customer preferences:
    The increasing prevalence of sensory organ diseases such as glaucoma, cataract, and macular degeneration has led to a surge in demand for sensory organ drugs. Additionally, the rise in the elderly population in China has also contributed to the market growth as they are more prone to sensory organ diseases.

    Trends in the market:
    The Sensory Organ Drugs market in China is witnessing a shift towards the adoption of innovative drugs. The market is currently dominated by traditional drugs, but the introduction of new drugs with advanced technologies is expected to change the market dynamics. Furthermore, the market is also experiencing a trend towards personalized medicine, where drugs are tailored to the specific needs of the patient.

    Local special circumstances:
    The Chinese government has been promoting the development of the pharmaceutical industry in the country, which has resulted in an increase in the number of domestic pharmaceutical companies. These companies are focusing on the development of innovative drugs to gain a competitive edge in the market. Additionally, the Chinese government has also been increasing its investment in the healthcare sector, which is expected to boost the market growth.

    Underlying macroeconomic factors:
    The increasing disposable income of the middle-class population in China has led to a rise in healthcare expenditure. This has resulted in an increase in demand for sensory organ drugs. Moreover, the government's initiative to provide universal healthcare coverage has also contributed to the market growth. Furthermore, the favorable regulatory environment in the country has attracted many multinational pharmaceutical companies to invest in the Chinese market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Sensory Organs Drugs: market data & analysis - BackgroundSensory Organs Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.